George Medicines announces GMRx2 presentations at the European Society of Cardiology Congress 2026

ConferenceGMRx2Positive

AI Analysis

Summary

George Medicines announced that GMRx2, a single-pill combination of telmisartan, amlodipine, and indapamide, has been selected for presentation at the European Society of Cardiology Congress 2026 in Munich from August 28-31.

Outcome Details

Data selected for presentation at European Society of Cardiology Congress 2026

Importance:3/10

Sentiment:

0.30

cardiologycombination therapylate-stageconference presentationcardiometabolic

Read the original article

Published by GlobeNewswire Pharma on August 20, 2026 11:00 AM

Read Original